Loading clinical trials...

The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer | Clinical Trials | Clareo Health

UNKNOWNNCT01310062

The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically ...

Lead sponsor: Ministry of Health, Malaysia•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Clinical Research Centre

CONTACT

+603-40439300 shanthini@crc.gov.my

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,600

Start dateAug 2010

Last updatedMar 7, 2011

Condition

Hepatitis B,Chronic Carcinoma,Hepatocellular

Locations shown

Sultanah Bahiyah Hospital

Alor Star, Kedah

Kuala Lumpur Hospital

Kuala Lumpur, Kuala Lumpur

Island Hospital

Pulau Pinang, Pulau Pinang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2011Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions